Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$37.76 USD
+0.48 (1.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $37.75 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Harmony Biosciences Holdings, Inc. (HRMY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$45.22 | $56.00 | $28.00 | 21.30% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Harmony Biosciences Holdings, Inc. comes to $45.22. The forecasts range from a low of $28.00 to a high of $56.00. The average price target represents an increase of 21.3% from the last closing price of $37.28.
Analyst Price Targets (9 )
Broker Rating
Harmony Biosciences Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.89 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on eight recommendations.
Of the nine recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 11.11% of all recommendations. A month ago, Strong Buy made up 62.5%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 5 | 5 | 5 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.89 | 2.00 | 2.00 | 2.00 | 1.89 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/10/2024 | UBS | Ashwani Verma | Not Available | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/7/2024 | Mizuho SecuritiesUSA | Graig Suvannavejh | Strong Buy | Strong Buy |
8/6/2024 | Needham & Company | Ami Fadia | Moderate Buy | Moderate Buy |
7/24/2024 | Cantor Fitzgerald & Co | Charles C Duncan | Strong Buy | Strong Buy |
7/14/2024 | Piper Sandler | David Amsellem | Strong Buy | Strong Buy |
6/21/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1/9/2024 | Goldman Sachs | Corinne Johnson | Strong Sell | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.89 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 9 |
Average Target Price | $45.22 |
LT Growth Rate | 22.80% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | 0.60 |
HRMY FAQs
Harmony Biosciences Holdings, Inc. (HRMY) currently has an average brokerage recommendation (ABR) of 1.89 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Harmony Biosciences Holdings, Inc. (HRMY) is $45.22. The current on short-term price targets is based on 3 reports.
The forecasts for Harmony Biosciences Holdings, Inc. (HRMY) range from a low of $28 to a high of $56. The average price target represents a increase of $19.76 from the last closing price of $37.76.
The current UPSIDE for Harmony Biosciences Holdings, Inc. (HRMY) is 19.76%
Based on short-term price targets offered by nine analysts, the average price target for Harmony Biosciences Holdings, Inc. comes to $45.22. The forecasts range from a low of $28.00 to a high of $56.00. The average price target represents an increase of 21.3% from the last closing price of $37.28.